Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Sep 07, 2026
L3Harris Technologies (LHX) Stock Falls -10.5% Amid Leadership Shakeup

L3Harris Technologies (LHX) Stock Falls -10.5% Amid Leadership Shakeup

Key Takeaways

  • L3Harris Technologies (LHX) shares closed near $256, down roughly 10.5% over the past 30 days and near the low end of a 52-week range of $256.05 to $379.23.
  • A leadership crisis—the ouster of Chairman and CEO Christopher Kubasik over conduct violations—was the primary near-term catalyst for the selloff.
  • Analyst downgrades and a securities-related investigation added to negative sentiment even as operating fundamentals remained intact.
  • Broader defense-sector budget uncertainty and investor positioning compounded the decline.

Company Snapshot: L3Harris Technologies (LHX)

L3Harris Technologies is a global aerospace and defense contractor headquartered in Melbourne, Florida, with roughly 45,000 employees and a market capitalization near $48 billion. The company operates through three segments: Space & Mission Systems (SMS), Communications & Spectrum Dominance (CSD), and Missile Solutions (MSL). Its portfolio spans satellite and missile-warning systems, tactical radios and waveforms, night-vision and sensor technology, and—following its 2023 acquisition of Aerojet Rocketdyne—propulsion, hypersonic, and solid rocket motor capabilities. L3Harris positions itself as a "sixth prime" U.S. defense contractor, competing with larger primes such as RTX and Northrop Grumman while pursuing a "trusted disruptor" strategy aimed at winning share on advanced programs.

Stock Performance Over the Past 30 Days and Quarter

Over the past 30 days, LHX declined from roughly $286.67 to a closing price of $256.45, a drop of approximately 10.5%. The shares have hovered near their 52-week low, with intraday action holding close to $256.05. The pullback is part of a longer slide: about three months ago the stock traded near $308, meaning LHX has fallen roughly 17% over the trailing quarter. The steady, staircase-like decline—punctuated by sharp down days around the CEO departure and a post-earnings selloff—reflects a market re-rating driven primarily by governance and defense-budget sentiment rather than a deterioration in reported financial results. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

What Drove the Recent Selloff

The dominant catalyst was governance. In mid-August, L3Harris announced that Chairman and CEO Christopher Kubasik had stepped down effective immediately after a board investigation found conduct inconsistent with the company's code of conduct. The board named insider Sam Mehta, who had led the SMS and CSD segments, as the new president and CEO. Shares dropped roughly 3% to 4% on the news, and the fallout continued as reports detailed years of employee concerns about the former chief executive. The episode triggered a securities-related investigation, with at least one law firm announcing a fraud-investigation opportunity for investors.

Analyst actions compounded the pressure. Jefferies resumed coverage with a downgrade to Hold from Buy, citing building uncertainty, while Deutsche Bank lowered its price target to $268 from $285. These moves outweighed constructive operating news, including a $139.01 million U.S. Navy contract modification and L3Harris's contribution to the successful launch of NASA's Nancy Grace Roman Space Telescope. Broader defense-budget worries—linked to uncertainty over the 2026 midterm elections and potential spending cuts—kept sector sentiment subdued, leaving LHX vulnerable to further downside.

Quarterly Trends and Underlying Fundamentals

The quarterly decline extends a multi-month theme: investors have de-rated defense names amid fears of slowing U.S. military spending. L3Harris fell sharply in mid-June and again in late July, even as its second-quarter results showed revenue up 8% to roughly $5.9 billion, GAAP earnings per share up 28% to $3.13, a book-to-bill ratio of 1.2x, and a backlog above $42 billion. The disconnect between solid fundamentals and falling share price points to sentiment-driven selling tied to governance headlines and Washington budget dynamics rather than weak execution. The CEO transition, ongoing investigations, and a leadership vacuum at the top have kept a valuation discount in place despite strong demand signals across space, missile, and communications programs. From what I see, this divergence is worth monitoring closely.

Factors to Watch in the Months Ahead

Investors will monitor several factors in the months ahead. The company's next earnings report, scheduled for late October, will be a key test of whether new CEO Sam Mehta can reaffirm the 2026 outlook and rebuild confidence. Progress on the Aerojet Rocketdyne Missile Solutions recapitalization—including the roughly $1 billion preferred-stock investment and the potential initial public offering of the AXYV subsidiary by 2027—could shape long-term valuation. Analysts maintain a consensus Buy rating with an average price target near $344, but the wide gap to the current price reflects skepticism about the governance overhang. Defense-budget outcomes tied to the 2026 midterms, order backlog conversion, and the resolution of the securities investigation will also be closely watched. I’m watching this closely as the situation evolves.

Using Tickeron’s AI Tools in My Research

In my analysis of names like LHX, I often turn to Tickeron’s AI Trading Bots to test different strategies against the stock’s recent patterns. The platform lets me review performance across various timeframes and approaches, which helps me stay objective when sentiment shifts quickly. It is one of the resources I check regularly to compare signals with traditional research.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: LHX

LHX's RSI Oscillator is staying in oversold zone for 11 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for LHX just turned positive on October 01, 2026. Looking at past instances where LHX's MACD turned positive, the stock continued to rise in 28 of 51 cases over the following month. The odds of a continued upward trend are 55%.

Following a +0.82% 3-day Advance, the price is estimated to grow further. Considering data from situations where LHX advanced for three days, in 161 of 309 cases, the price rose further within the following month. The odds of a continued upward trend are 52%.

LHX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LHX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.

The Aroon Indicator for LHX entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.226) is normal, around the industry mean (6.305). P/E Ratio (24.010) is within average values for comparable stocks, (58.116). Projected Growth (PEG Ratio) (1.183) is also within normal values, averaging (2.564). Dividend Yield (0.021) settles around the average of (0.009) among similar stocks. P/S Ratio (2.055) is also within normal values, averaging (18.330).

The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating fairly steady price growth. LHX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 72 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 73 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 85 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LHX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 38.94B. The market cap for tickers in the group ranges from 4.49 to 1.92T. SPCX holds the highest valuation in this group at 1.92T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -1%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was -11%. SPCX experienced the highest price growth at 18%, while PUSA experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 19%. For the same stocks of the Industry, the average monthly volume growth was 41% and the average quarterly volume growth was -24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 45
P/E Growth Rating: 70
Price Growth Rating: 62
SMR Rating: 77
Profit Risk Rating: 76
Seasonality Score: 14 (-100 ... +100)
View a ticker or compare two or three
LHX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an agile global aerospace and defense technology innovator, which engages in the provision of defense and commercial technologies across air, land, sea, space and cyber domains.

Industry AerospaceDefense

Industry
N/A
Address
1025 West NASA Boulevard
Phone
+1 321 727-9100
Employees
45000
Web
https://www.l3harris.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
GE Aerospace (GE) stock declined -12% over the past 30 days, falling from around $333 to $293, amid profit-taking after record highs near $348. Over the past quarter, the stock is down -8%, reflecting post-earnings selloff despite strong Q4 2025 results with 20% revenue growth.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
Sable Offshore Corp. (SOC) shares fell 7.40% in the most recent completed session, closing at $16.52 versus a prior close of $17.84. The pullback followed a volatile stretch in which SOC traded between $15.76 and $19.21 over just two sessions, reflecting profit‑taking after a strong run in March.
NBR stock rose approximately +12% over the last 30 days, driven by positive momentum in the oil and gas drilling sector and strong Q4 earnings beat. Over the past quarter, the stock surged +58%, fueled by robust YTD performance, debt reduction efforts, and improved operational results in international drilling.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).